Accueil
cg-1

CG Oncology Raises $380 Million in Nasdaq IPO Priced Above Range

Par un écrivain mystérieux

Description
CG Oncology Raises $380 Million in Nasdaq IPO Priced Above Range
A Record Pace for IPOs
CG Oncology Raises $380 Million in Nasdaq IPO Priced Above Range
Cg Oncology Shares Open At $29 In Nasdaq Debut Vs Ipo Price Of $… - 2024-01-25
CG Oncology Raises $380 Million in Nasdaq IPO Priced Above Range
Cancer drug developer CG Oncology valued at $1.75 bln in strong debut
CG Oncology Raises $380 Million in Nasdaq IPO Priced Above Range
Cancer drug developer CG Oncology valued at $1.75 bln in strong debut
CG Oncology Raises $380 Million in Nasdaq IPO Priced Above Range
Partnology
CG Oncology Raises $380 Million in Nasdaq IPO Priced Above Range
Schott Gains After Staging Germany's Biggest IPO This Year - Bloomberg
CG Oncology Raises $380 Million in Nasdaq IPO Priced Above Range
CG Oncology brings in $380M from first biotech IPO of 2023
CG Oncology Raises $380 Million in Nasdaq IPO Priced Above Range
Kimberly Ha on LinkedIn: CG Oncology, Inc. Rings the Opening Bell
CG Oncology Raises $380 Million in Nasdaq IPO Priced Above Range
CG Oncology IPO rockets 96% in sign of pent-up deal demand
CG Oncology Raises $380 Million in Nasdaq IPO Priced Above Range
ArriVent Biopharma goes public through upsized $175M IPO - Philadelphia Business Journal
CG Oncology Raises $380 Million in Nasdaq IPO Priced Above Range
Deal Point Data - Merger Agreements, Corporate Governance, IPOs, High Yield Debt Covenants, Spin Offs
CG Oncology Raises $380 Million in Nasdaq IPO Priced Above Range
IPO Tracker - Life Sciences Perspectives
CG Oncology Raises $380 Million in Nasdaq IPO Priced Above Range
Reddit Advised to Target at Least $5 Billion Value in IPO - Bloomberg
CG Oncology Raises $380 Million in Nasdaq IPO Priced Above Range
Temasek-Backed UST Seeks to Raise at Least $500 Million in IPO - Bloomberg
depuis par adulte (le prix varie selon la taille du groupe)